• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Emergence of multidrug-resistant Salmonella enterica serotype Typhimurium phage-type DT104 among salmonellae causing enteritis in Israel.以色列引起肠炎的沙门氏菌中多重耐药性肠炎沙门氏菌鼠伤寒血清型噬菌体类型DT104的出现。
Epidemiol Infect. 1998 Dec;121(3):555-9. doi: 10.1017/s0950268898001526.
2
Emergence of multidrug-resistant Salmonella enterica serotype typhimurium DT104 infections in the United States.美国多重耐药性肠炎沙门氏菌鼠伤寒血清型DT104感染的出现。
N Engl J Med. 1998 May 7;338(19):1333-8. doi: 10.1056/NEJM199805073381901.
3
An outbreak of multidrug-resistant, quinolone-resistant Salmonella enterica serotype typhimurium DT104.多重耐药、耐喹诺酮的肠炎沙门氏菌鼠伤寒血清型DT104暴发。
N Engl J Med. 1999 Nov 4;341(19):1420-5. doi: 10.1056/NEJM199911043411902.
4
Epidemiology and characterization of animal Salmonella enterica subspecies Enterica serotype typhimurium DT104 in Hungary.匈牙利动物肠炎沙门氏菌肠炎亚种鼠伤寒血清型DT104的流行病学及特征分析
Acta Vet Hung. 2000;48(4):407-20.
5
Multiple clones within multidrug-resistant Salmonella enterica serotype Typhimurium phage type DT104. The Greek Nontyphoidal Salmonella Study Group.多重耐药性肠炎沙门氏菌鼠伤寒血清型DT104中的多个克隆。希腊非伤寒沙门氏菌研究小组。
J Clin Microbiol. 2000 Mar;38(3):1269-71. doi: 10.1128/JCM.38.3.1269-1271.2000.
6
Dissemination of Salmonella enterica serotype agona and multidrug-resistant Salmonella enterica serotype typhimurium in Cuba.古巴肠炎沙门氏菌阿贡纳血清型及多重耐药性肠炎沙门氏菌鼠伤寒血清型的传播情况
Am J Trop Med Hyg. 2006 Jun;74(6):1049-53.
7
Antimicrobial drug resistance in non-typhoidal salmonellas from humans in England and Wales in 1999: decrease in multiple resistance in Salmonella enterica serotypes Typhimurium, Virchow, and Hadar.1999年英格兰和威尔士人类非伤寒沙门氏菌的抗菌药物耐药性:肠炎沙门氏菌鼠伤寒血清型、维尔肖血清型和哈达尔血清型多重耐药性的下降
Microb Drug Resist. 2000 Winter;6(4):319-25. doi: 10.1089/mdr.2000.6.319.
8
Multidrug-resistant strains of Salmonella enterica Typhimurium, United States, 1997-1998.1997 - 1998年美国肠炎沙门氏菌鼠伤寒血清型多重耐药菌株
Emerg Infect Dis. 2004 May;10(5):795-801. doi: 10.3201/eid1005.030209.
9
Analysis of integrons in human isolates of Salmonella enterica serovar typhimurium isolated in the Slovak Republic.对斯洛伐克共和国分离出的肠炎沙门氏菌鼠伤寒血清型人类分离株中的整合子进行分析。
FEMS Microbiol Lett. 2004 Oct 1;239(1):25-31. doi: 10.1016/j.femsle.2004.08.013.
10
Antimicrobial resistance and phage and molecular typing of Salmonella strains isolated from food for human consumption in Spain.西班牙从供人类食用的食品中分离出的沙门氏菌菌株的抗菌耐药性以及噬菌体和分子分型
J Food Prot. 2007 Dec;70(12):2741-8. doi: 10.4315/0362-028x-70.12.2741.

引用本文的文献

1
Multidrug-resistant Salmonella enterica serovar Muenchen from pigs and humans and potential interserovar transfer of antimicrobial resistance.来自猪和人类的多重耐药性肠炎沙门氏菌慕尼黑血清型及抗菌药物耐药性的潜在血清型间转移。
Antimicrob Agents Chemother. 2005 Feb;49(2):503-11. doi: 10.1128/AAC.49.2.503-511.2005.
2
Multiple outbreaks of nosocomial salmonellosis in Russia and Belarus caused by a single clone of Salmonella enterica serovar Typhimurium producing an extended-spectrum beta-lactamase.俄罗斯和白俄罗斯发生多起医院内沙门氏菌病暴发,由一株产超广谱β-内酰胺酶的肠炎沙门氏菌鼠伤寒血清型单一克隆菌株引起。
Antimicrob Agents Chemother. 2004 Aug;48(8):2808-15. doi: 10.1128/AAC.48.8.2808-2815.2004.
3
Molecular characterization of multidrug-resistant Salmonella enterica subsp. enterica serovar Typhimurium isolates from swine.来自猪的多重耐药性肠炎沙门氏菌肠炎亚种鼠伤寒血清型分离株的分子特征分析
J Clin Microbiol. 2002 Aug;40(8):2813-22. doi: 10.1128/JCM.40.8.2813-2822.2002.
4
Characterization of Salmonella enterica serovar typhimurium DT104 isolated from Denmark and comparison with isolates from Europe and the United States.对从丹麦分离出的肠炎沙门氏菌鼠伤寒血清型DT104进行特性分析,并与来自欧洲和美国的分离株进行比较。
J Clin Microbiol. 2000 Apr;38(4):1581-6. doi: 10.1128/JCM.38.4.1581-1586.2000.

以色列引起肠炎的沙门氏菌中多重耐药性肠炎沙门氏菌鼠伤寒血清型噬菌体类型DT104的出现。

Emergence of multidrug-resistant Salmonella enterica serotype Typhimurium phage-type DT104 among salmonellae causing enteritis in Israel.

作者信息

Metzer E, Agmon V, Andoren N, Cohen D

机构信息

Department of Molecular Virology, The Faculty of Medicine, Hebrew University of Jerusalem.

出版信息

Epidemiol Infect. 1998 Dec;121(3):555-9. doi: 10.1017/s0950268898001526.

DOI:10.1017/s0950268898001526
PMID:10030704
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2809562/
Abstract

The relative frequency of salmonella strains isolated from hospitalized and non-hospitalized patients in Southern Israel changed during the period, 1994-6. Salmonella enterica serotype Typhimurium definitive phage-type 104 (DT104) appeared in Israel in 1994 and became the most prevalent strain in 1996. An outbreak of enteritis due to Salmonella enterica serotype Agona occurred in Israel, in October 1994 and lasted for 4 months. The relative frequency of Salmonella enterica serotype Enteritidis remained almost constant during these years, with seasonal fluctuations only. The importance of the increase in the prevalence of Typhimurium DT104 has been the epidemic spread of a multiresistant strain of R-type ACT (A, ampicillin; C, chloramphenicol; T, tetracycline) belonging to this phage-type. Since 1995 the frequency of Typhimurium DT104 isolates that possess, in addition to the above R-type, a chromosomally encoded resistance to the quinolone drug, nalidixic acid, increased tenfold. In 1996, 27% of the Typhimurium DT104 isolates were of R-type ACTN. S. Enteritidis exhibited over 95% susceptibility to at least eight of the most commonly used antibiotic drugs, and none of the isolates was resistant to quinolone or fluoroquinoline.

摘要

1994 - 1996年期间,从以色列南部住院和非住院患者中分离出的沙门氏菌菌株的相对频率发生了变化。肠炎沙门氏菌鼠伤寒亚种定型噬菌体104型(DT104)于1994年出现在以色列,并于1996年成为最普遍的菌株。1994年10月,以色列发生了由肠炎沙门氏菌阿贡纳血清型引起的肠炎疫情,持续了4个月。这些年里,肠炎沙门氏菌肠炎血清型的相对频率几乎保持不变,仅存在季节性波动。鼠伤寒DT104患病率增加的重要性在于,属于该噬菌体类型的R型ACT(A,氨苄青霉素;C,氯霉素;T,四环素)多耐药菌株的流行传播。自1995年以来,除上述R型外,还对喹诺酮类药物萘啶酸具有染色体编码抗性的鼠伤寒DT104分离株的频率增加了10倍。1996年,27%的鼠伤寒DT104分离株为R型ACTN。肠炎沙门氏菌对至少八种最常用的抗生素药物的敏感性超过95%,且没有分离株对喹诺酮或氟喹诺酮耐药。